This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Haemonetics: Cutting-Edge Innovation

By Battle Road Research, an equity research firm.

NEW YORK ( TheStreet ) -- Haemonetics (HAE - Get Report) produces and develops products that are changing the way blood is collected, stored and donated.

Most people encounter a Victorian process when donating blood. They have a vein opened, allowing their blood to drip through tubing into a bag, which is stored in a cooler for transport. Even though blood traditionally has been collected "whole" like this, it is rarely given to patients in whole form.

But Braintree, Mass-based Haemonetics, with annual revenue of about $600 million and a market cap of $1.4 billion, manufactures devices that collect different blood components separately.

As you probably know, blood is composed of a few important important components: plasma (a straw-colored medium for the other components), red blood cells (which deliver oxygen) and platelets (for clotting). A fourth component, white blood cells, is important to the body's immune system, but it cannot be donated from one person to another.

Of the three main components that can be transferred from donor to patient, plasma has yielded the most revenue for Haemonetics.

As a method of ensuring recurring revenue from its devices and eliminating high capital costs, Haemonetics will often place its equipment at blood banks or other collection centers and generate revenue from disposable products utilized in the devices.

Haemonetics' vertical integration across all facets of blood management is unique. The company manufactures a wide variety of products that aid in putting blood back into hospital patients. For example, the company has a product called OrthoPAT, which collects blood lost during and after orthopedic surgeries, cleans it, and transfuses it back into the patient. This reduces the need for donor blood for these operations, conserving it for trauma and other high-use needs.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
HAE $31.82 1.10%
AAPL $109.50 -1.16%
FB $92.47 0.08%
GOOG $638.31 -0.63%
TSLA $226.00 -2.60%


Chart of I:DJI
DOW 17,050.75 +138.46 0.82%
S&P 500 1,995.83 +15.91 0.80%
NASDAQ 4,810.7880 +19.6360 0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs